Nobel prizes, cancer drugs and $280 million just part of Carol Mimura’s UC Berkeley legacy

Before Carol Mimura, UC Berkeley’s drug discoveries were languishing. Now they’re benefitting millions and bringing in more than $280 million to the world’s foremost public university.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Advertisement — Advertise with Biotech Networks